Diabetic maculopathy and lipid-lowering therapy

被引:0
|
作者
A Misra
N K Vikram
A Kumar
机构
[1] All India Institute of Medical Sciences,Department of Medicine
[2] Dr RP Center for Ophthalmology,undefined
[3] All India Institute of Medical Sciences,undefined
来源
Eye | 2004年 / 18卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:107 / 108
页数:1
相关论文
共 50 条
  • [1] Diabetic maculopathy and lipid-lowering therapy
    Misra, A
    Vikram, NK
    Kumar, A
    EYE, 2004, 18 (01) : 107 - 108
  • [2] LIPID-LOWERING THERAPY IN PERSPECTIVE
    THOMPSON, GR
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (02): : 61 - 64
  • [3] The Future of Lipid-Lowering Therapy
    van Zwol, Willemien
    Rimbert, Antoine
    Kuivenhoven, Jan Albert
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
  • [4] The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    Chowdhury, T
    Hopkins, D
    Dodson, PM
    Vafidis, GC
    EYE, 2002, 16 (06) : 689 - 693
  • [5] The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    T A Chowdhury
    D Hopkins
    P M Dodson
    G C Vafidis
    Eye, 2002, 16 : 689 - 693
  • [6] Intensive lipid-lowering therapy in high-risk diabetic patients
    Masaaki Miyata
    Hypertension Research, 2021, 44 : 1676 - 1677
  • [7] Intensive lipid-lowering therapy in high-risk diabetic patients
    Miyata, Masaaki
    HYPERTENSION RESEARCH, 2021, 44 (12) : 1676 - 1677
  • [8] THE PROBLEM OF SAFETY OF LIPID-LOWERING THERAPY
    Zykov, M., V
    KARDIOLOGIYA, 2019, 59 (05) : 13 - 26
  • [9] LIPID-LOWERING THERAPY STRIKES AGAIN
    Pantea, R.
    Zara, C.
    Chirita-Emandi, A.
    Ivascu, M.
    Balahura, A. -M.
    ATHEROSCLEROSIS, 2023, 379 : S171 - S171
  • [10] Lipid-lowering therapy in membranous nephropathy
    Haas, M
    Kerjaschki, D
    Mayer, G
    KIDNEY INTERNATIONAL, 1999, 56 : S110 - S112